GLOBAL FACTOR VIII DEFICIENCY TREATMENT MARKET ANALYSIS

Global factor VIII deficiency treatment Market, By Product Type (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Biologic (Hemlibra), Desmopressin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Apr 2023
Code : CMI3257
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Factor VIII Deficiency Treatment Market- Regional Analysis

Among all regions, North America is expected to dominate the global market over the forecast period. This is attributed to North America holding a 39.5% market share and due to the presence of major players such as Baxter, Biogen, Inc., Bayer AG, and others contributing to the development of the factor VIII deficiency treatment market in North America.

The Asia Pacific region is expected to be the second dominating region over the forecast period, due to an increase in the number of people suffering from hemophilia. For instance, according to an article published in springer nature, an open-access scientific journal, in September 2020, the number of people suffering from hemophilia each year in India is between 100,000 – 125,000

North America: U.S. and Canada

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Middle East: GCC Countries, Israel, and Rest of Middle East

Africa: South Africa, North Africa, and Central Africa